(NASDAQ: PAVM) Pavmed's forecast annual revenue growth rate of 1,623.45% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 12.39%, and it is also forecast to beat the US market's average forecast revenue growth rate of 1,540.38%.
Pavmed's revenue in 2026 is $29,000.On average, 4 Wall Street analysts forecast PAVM's revenue for 2026 to be $494,334, with the lowest PAVM revenue forecast at $465,256, and the highest PAVM revenue forecast at $519,259.
In 2027, PAVM is forecast to generate $185,222,015 in revenue, with the lowest revenue forecast at $177,962,286 and the highest revenue forecast at $190,671,758.